139 related articles for article (PubMed ID: 1521438)
21. Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS.
Radermacher P; Santak B; Wüst HJ; Tarnow J; Falke KJ
Intensive Care Med; 1990; 16(4):227-32. PubMed ID: 2113542
[TBL] [Abstract][Full Text] [Related]
22. Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy.
Bush A; Busst C; Knight WB; Shinebourne EA
Am Rev Respir Dis; 1987 Sep; 136(3):767-9. PubMed ID: 3307574
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of postoperative pulmonary hypertensive crisis.
Wheller J; George BL; Mulder DG; Jarmakani JM
Circulation; 1979 Dec; 60(7):1640-4. PubMed ID: 498483
[TBL] [Abstract][Full Text] [Related]
24. The use of oxygen and prostacyclin as pulmonary vasodilators in congenital heart disease.
Bush A; Busst CM; Shinebourne EA
Int J Cardiol; 1985 Nov; 9(3):267-74. PubMed ID: 3902674
[TBL] [Abstract][Full Text] [Related]
25. [Progressive pulmonary hypertension following repair of pseudotruncus arteriosus with major aorto-pulmonary collateral arteries in a 20-year-old patient].
Miura T; Matsuda H; Nakano S; Hirose H; Kawashima Y; Ihara K
Nihon Kyobu Geka Gakkai Zasshi; 1989 Mar; 37(3):546-50. PubMed ID: 2768930
[TBL] [Abstract][Full Text] [Related]
26. The place of prostacyclin in the clinical management of primary pulmonary hypertension.
Higenbottam T
Am Rev Respir Dis; 1987 Sep; 136(3):782-5. PubMed ID: 3307576
[TBL] [Abstract][Full Text] [Related]
27. Prostacyclin aerosol in an infant with pulmonary hypertension.
Santak B; Schreiber M; Kuen P; Lang D; Radermacher P
Eur J Pediatr; 1995 Mar; 154(3):233-5. PubMed ID: 7758525
[TBL] [Abstract][Full Text] [Related]
28. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?
Bush A; Busst C; Booth K; Knight WB; Shinebourne EA
Circulation; 1986 Jul; 74(1):135-44. PubMed ID: 3518981
[TBL] [Abstract][Full Text] [Related]
29. Effects of hyperventilation on prostacyclin formation and on pulmonary vasodilation after group B beta-hemolytic streptococci-induced pulmonary hypertension.
Hammerman C; Aramburo MJ
Pediatr Res; 1991 Mar; 29(3):282-7. PubMed ID: 2034476
[TBL] [Abstract][Full Text] [Related]
30. Thermal laser arterial injury and prostacyclin administration in dogs: thrombotic and hyperplastic consequences.
Hehrlein C; Svenson RH; McKusik AP; Chuang CH; Tuntelder JR; Tatsis GP; Littmann L; Thompson M
J Cardiovasc Surg (Torino); 1992; 33(3):366-71. PubMed ID: 1601923
[TBL] [Abstract][Full Text] [Related]
31. Effect of tolazoline on persistent hypoxemia in severe hyaline membrane disease.
Park KI; Namgung R; Lee C; Han DG
Yonsei Med J; 1990 Jun; 31(2):156-62. PubMed ID: 2219973
[TBL] [Abstract][Full Text] [Related]
32. Prostacyclin and PGE1 treatment of pulmonary hypertension.
Long WA; Rubin LJ
Am Rev Respir Dis; 1987 Sep; 136(3):773-6. PubMed ID: 3307575
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension.
Weesner KM
Cathet Cardiovasc Diagn; 1991 Sep; 24(1):10-5. PubMed ID: 1913785
[TBL] [Abstract][Full Text] [Related]
34. Different hemodynamic responses between acute and chronic infusion of iloprost (prostacyclin-stable analogue) in severe pulmonary hypertension.
Gomez-Sanchez MA; de la Calzada CS; Gomez Pajuelo C; Tascon JC; Alonso M; Andreu J; Aranzana M; de la Fuente A
Am Rev Respir Dis; 1991 Dec; 144(6):1404-5. PubMed ID: 1720602
[TBL] [Abstract][Full Text] [Related]
35. The hemodynamic effects of prostacyclin infusions in normotensive and ACTH induced hypertensive conscious sheep.
Mason RT; Allen KJ; Coghlan JP; Denton DA; Fei DT; Graham WF; Stewart KW; Scoggins BA
Prostaglandins Leukot Med; 1984 Oct; 16(1):57-68. PubMed ID: 6096893
[TBL] [Abstract][Full Text] [Related]
36. Persistent pulmonary hypertension in a newborn with congenital diaphragmeatic hernia: successful management with tolazoline.
Levy RJ; Rosenthal A; Freed MD; Smith CD; Eraklis A; Nadas AS
Pediatrics; 1977 Nov; 60(5):740-2. PubMed ID: 917638
[No Abstract] [Full Text] [Related]
37. Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension.
Palevsky HI; Long W; Crow J; Fishman AP
Circulation; 1990 Dec; 82(6):2018-26. PubMed ID: 2242526
[TBL] [Abstract][Full Text] [Related]
38. Use of tolazoline in newborn infants with diaphragmatic hernia and severe cardiopulmonary disease. A preliminary report.
Moodie DS; Telander RL; Kleinberg F; Feldt RH
J Thorac Cardiovasc Surg; 1978 May; 75(5):725-9. PubMed ID: 642568
[TBL] [Abstract][Full Text] [Related]
39. [Experimental studies on the behavior of intracranial pressure under prostacyclin application].
Seifert V; Stolke D
Neurochirurgia (Stuttg); 1985 Mar; 28(2):40-5. PubMed ID: 3887195
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects of tolazoline and ranitidine.
Bush A; Busst CM; Knight WB; Shinebourne EA
Arch Dis Child; 1987 Mar; 62(3):241-6. PubMed ID: 3566316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
